- Home
- HAFN vs PRGO Comparison
HAFN vs PRGO Comparison
Compare HAFN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- PRGO
- Stock Information
- Founded
- HAFN 2012
- PRGO 1887
- Country
- HAFN Singapore
- PRGO Ireland
- Employees
- HAFN N/A
- PRGO N/A
- Industry
- HAFN
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- HAFN
- PRGO Health Care
- Exchange
- HAFN Nasdaq
- PRGO Nasdaq
- Market Cap
- HAFN 2.7B
- PRGO 3.1B
- IPO Year
- HAFN N/A
- PRGO 1991
- Fundamental
- Price
- HAFN $6.15
- PRGO $22.54
- Analyst Decision
- HAFN Strong Buy
- PRGO Buy
- Analyst Count
- HAFN 1
- PRGO 4
- Target Price
- HAFN $6.50
- PRGO $33.00
- AVG Volume (30 Days)
- HAFN 1.3M
- PRGO 1.5M
- Earning Date
- HAFN 08-27-2025
- PRGO 11-05-2025
- Dividend Yield
- HAFN 10.43%
- PRGO 5.14%
- EPS Growth
- HAFN N/A
- PRGO N/A
- EPS
- HAFN 0.84
- PRGO N/A
- Revenue
- HAFN $2,354,657,000.00
- PRGO $4,326,100,000.00
- Revenue This Year
- HAFN N/A
- PRGO $2.28
- Revenue Next Year
- HAFN $0.58
- PRGO $0.54
- P/E Ratio
- HAFN $7.17
- PRGO N/A
- Revenue Growth
- HAFN N/A
- PRGO N/A
- 52 Week Low
- HAFN $3.61
- PRGO $21.03
- 52 Week High
- HAFN $7.84
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- HAFN 58.41
- PRGO 37.33
- Support Level
- HAFN $5.98
- PRGO $22.00
- Resistance Level
- HAFN $6.43
- PRGO $23.68
- Average True Range (ATR)
- HAFN 0.16
- PRGO 0.52
- MACD
- HAFN -0.01
- PRGO 0.00
- Stochastic Oscillator
- HAFN 57.59
- PRGO 21.69
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.